The national drug regulatory authority has heightened its monitoring of the distribution channels for GLP-1-based weight loss medications. This initiative comes in response to increasing reports of unauthorized sales and misuse.
Coordinated inspections took place at 49...
An AIIMS expert has highlighted that the generic version of semaglutide has been launched in India, offering significant cost savings compared to existing branded products. Dr. Nikhil Tandon, a professor and head of the Department of...
GLP-1, or Glucagon-Like Peptide-1, has gained significant attention for its role in weight loss and managing diabetes. This hormone helps regulate appetite and insulin...
In recent years, the use of injectable weight-loss medications, particularly GLP-1 drugs like Wegovy and Zepbound, has become increasingly widespread. However, a pertinent question...
Medications initially developed for managing diabetes and obesity are broadening their therapeutic applications. Recently, treatments based on the hormone GLP-1 have demonstrated benefits not...
Quick-fix slimming hacks continue to dominate social media feeds, often overshadowing safety concerns. From unverified fat-burning drinks to mystery shots, many people chase rapid...
Danish pharmaceutical giant Novo Nordisk has officially launched its much-awaited weight loss drug, Wegovy, in India. With obesity rates rising sharply across the country,...
